Sales of Dong-A grow 7% in 2011

Published: 2012-02-14 06:56:00

Updated: 2012-02-14 06:56:00

The sales of Dong-A Pharma grew 7 percent on-year in 2011 thanks to Bacchus’s reclassification into OTC product and its partnership with GlaxoSmithKline (GSK), the world’s third largest pharmaceutical firm.

Dong-A reported Friday that its revenue rose 7 percent to 907.3 billion won last year c...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK